05:06 PM EST, 12/06/2024 (MT Newswires) -- Saurabh Saha, Director, Chief Executive Officer, on December 06, 2024, sold 87,496 shares in Centessa Pharmaceuticals ( CNTA ) for $1,615,255. Following the Form 4 filing with the SEC, Saha has control over a total of 613,661 shares of the company, with 575,661 shares held directly and 38,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1847903/000184790324000178/xslF345X05/wk-form4_1733522614.xml